Welcome to our dedicated page for AI / ML Innovations news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML Innovations stock.
AI/ML Innovations Inc. develops artificial intelligence and neural-network technology for digital health applications. The company’s platforms use signal processing and deep learning to convert biometric data into clinical insights, with recurring updates centered on ECG analysis, heart rate variability analytics, remote cardiac monitoring, and cardiovascular research support.
News for AIMLF also covers activity at its Neural Cloud Solutions subsidiary, including MaxYield™, CardioYield™, and Insight 360™ commercialization, reseller and distribution agreements, research-services collaborations, medical advisory board appointments, and capital-structure actions such as private placements, convertible debentures, warrants, options, and share issuances for debt settlement.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced that FINRA has approved a change in its stock trading symbol from FIRZF to AIMLF. This change is effective immediately and allows the company's common shares to trade on the OTCQB Market. The company aims to leverage artificial intelligence (AI) and machine learning (ML) technologies, particularly in the digital healthcare sector, where it has acquired a 70% stake in Health Gauge.